Suicide PreventionNCT06842667
Development and Preliminary Testing of a "Papageno"-Story Interview Intervention- Aim 3
A study testing Papageno video in people with Suicide Prevention, run by University of Michigan at 1 site in United States.
Trial summary
The purpose of this study is to determine the effects of a short "Papageno story" video of a compilation of interviews on proximal risk factors for suicide. The researchers believe that the intervention may increase protective factors related to suicide. Read more about this study
- Who is it for?
- Ages 18 to 24 years
- Conditions the study is for
- Suicide Prevention
- What is being tested?
- Papageno video
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 506 participants
- Where
- 1 siteUnited States
- Study dates
- 17 Sep 2025to 6 Oct 2025
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 24 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- People who are part of an existing cohort within DesignXM
- They will also answer yes to the question: "In the past 1 year, have you wished you were dead or wished you could go to sleep and not wake up?"
Who cannot join
- No exclusions if all inclusion criteria is met
Trial locations and contacts
1 site in 1 country.
About this study
The purpose of this study is to determine the effects of a short "Papageno story" video of a compilation of interviews on proximal risk factors for suicide. The researchers believe that the intervention may increase protective factors related to suicide.
Read the detailed description
Update 4/20/2026: We changed the study design section from "randomized" to "non-randomized" to reflect a change that was brought to our attention. The platform we used for this study did not use a randomizing function, but rather, individuals were presented with surveys on their dashboards. They only became aware of the surveys' content once they clicked the link and began the session. They were not allowed to respond to both the "Papageno" and the active control surveys.
- Conditions
- Suicide Prevention
- Being tested
- Papageno video, Control video
- Medical subject headings
- Suicide Prevention
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Papageno videoBehavioural
The intervention will be a video (14 min 13 sec in length) of a series of clips from the "Papageno" interviews developed during the pilot phase of this project. The decision to combine the videos and shorten the total length of the video was based on the feedback we received during the acceptability and feasibility phase of this study. Interviewees were asked questions about a time in their life when they came close to suicide but found non-suicide alternatives (their "Papageno" story).
Control videoBehavioural
The control condition will involve viewing a mental health education video (12 min 14 sec in length) created by our team. It is a simple informational video, aimed at psychoeducation about suicide and safety promotion. It includes a list of mental health and crisis resources. Both videos are interview-style.
| Study group | Role | What they receive |
|---|---|---|
| Papageno video | Experimental | The arm will watch a compilation of interviews on proximal risk factors for suicide Receives: Behavioral: Papageno video |
| Control video | Active comparator | The arm will watch an educational control video Receives: Behavioral: Control video |
What is being measured
The primary outcome is the main question the study is designed to answer.
Suicidal ideation
Assessed with the Abbreviated Reasons For Living- Young Adult Abbreviated (RFL-YA-II) which consists of 24 questions rated on a scale of 1-6. Higher scores indicate greater importance.
Measured: Immediately before and after watching the video and at 3 months
Hopelessness
Assessed with the Beck Hopelessness Scale-4 (BHS-4). The BHS-4 assesses participants' sense of hopelessness, including perceptions of whether their personal actions can improve future outcomes. Participants rate 4 items using a 4 point Likert scale (e.g. "My future seems dark to me"). Each question is coded 0 for positive expectations and 1 for negative expectations.
Measured: Immediately before and after watching the video and at 3 months
Secondary outcomes (1)
Participant perceived agency
As measured by the Perceived Control Scale which is a single-item measure of participant perceived control. Participants will rate agreement with the statement, "right now, I feel like things are out of my control" from 0-10 ("not at all" to "a lot").
Measured: Immediately before and after watching the video and at 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted24 Feb 2025
- Study start17 Sep 2025
- Primary completion6 Oct 2025
- Study completion6 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Suicide PreventionStudies of the same condition, open and under way.
- More trials run by University of MichiganThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 506 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Michigan
- Sponsor type
- University, hospital or other
- Collaborators
- American Foundation for Suicide Prevention, Ouida Scholar Award
- Responsible party
- Principal investigator, Jane Harness, University of Michigan
- Investigators
- Jane Harness, DO, Principal investigator, University of MichiganCheryl King, PhD, Principal investigator, University of Michigan
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06842667
- Sponsor's protocol ID
- HUM00266531
- Other IDs
- SRG-1-123-19
- Status last verified
- Apr 2026
- First submitted
- 18 Feb 2025
- Last updated
- 23 Apr 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Yes: De-identified individual participant data that underlie the results reported.
Study at a glance
From the registry record, last updated by the sponsor on 23 Apr 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Development and Preliminary Testing of a "Papageno"-Story Interview Intervention- Aim 3
- ClinicalTrials.gov ID
- NCT06842667
- Acronym / sponsor ID
- HUM00266531
- Conditions
- Suicide Prevention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 506 participants (actual)
- Lead sponsor
- University of MichiganUniversity, hospital or other
- Collaborators
- American Foundation for Suicide Prevention, Ouida Scholar Award
- Study start
- 17 Sep 2025 (actual)
- Primary completion
- 6 Oct 2025 (actual)
- Study completion
- 6 Oct 2025 (actual)
- First posted
- 24 Feb 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to determine the effects of a short "Papageno story" video of a compilation of interviews on proximal risk factors for suicide. The researchers believe that the intervention may increase protective factors related to suicide.
Detailed description
Update 4/20/2026: We changed the study design section from "randomized" to "non-randomized" to reflect a change that was brought to our attention. The platform we used for this study did not use a randomizing function, but rather, individuals were presented with surveys on their dashboards. They only became aware of the surveys' content once they clicked the link and began the session. They were not allowed to respond to both the "Papageno" and the active control surveys.
Study design
- Primary purpose
- Prevention
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Papageno video | Experimental | Behavioral: Papageno videoThe arm will watch a compilation of interviews on proximal risk factors for suicide |
| Control video | Active comparator | Behavioral: Control videoThe arm will watch an educational control video |
Who may qualify
- Ages
- 18 to 24 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- People who are part of an existing cohort within DesignXM
- They will also answer yes to the question: "In the past 1 year, have you wished you were dead or wished you could go to sleep and not wake up?"
Key exclusion criteria (1 listed)
- No exclusions if all inclusion criteria is met
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Papageno videoThe intervention will be a video (14 min 13 sec in length) of a series of clips from the "Papageno" interviews developed during the pilot phase of this project. The decision to combine the videos and shorten the total length of the video was based on the feedback we received during the acceptability and feasibility phase of this study. Interviewees were asked questions about a time in their life when they came close to suicide but found non-suicide alternatives (their "Papageno" story). | Behavioural | Papageno video |
| Control videoThe control condition will involve viewing a mental health education video (12 min 14 sec in length) created by our team. It is a simple informational video, aimed at psychoeducation about suicide and safety promotion. It includes a list of mental health and crisis resources. Both videos are interview-style. | Behavioural | Control video |
Primary outcome
Suicidal ideation
Time frame: Immediately before and after watching the video and at 3 months
Assessed with the Abbreviated Reasons For Living- Young Adult Abbreviated (RFL-YA-II) which consists of 24 questions rated on a scale of 1-6. Higher scores indicate greater importance.
Hopelessness
Time frame: Immediately before and after watching the video and at 3 months
Assessed with the Beck Hopelessness Scale-4 (BHS-4). The BHS-4 assesses participants' sense of hopelessness, including perceptions of whether their personal actions can improve future outcomes. Participants rate 4 items using a 4 point Likert scale (e.g. "My future seems dark to me"). Each question is coded 0 for positive expectations and 1 for negative expectations.
1 secondary outcome
Participant perceived agency
Time frame: Immediately before and after watching the video and at 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Apr 2026.
- Individual participant dataSharing planned: Yes. De-identified individual participant data that underlie the results reported.
Related trials for Suicide Prevention
Recruiting
Preventing Suicidal Behavior With Diverse High-Risk Youth in Acute Care Settings
Suicide, Attempted, Suicide Ideation
Recruiting
Exploring The Effect of TikTok Trigger Warnings in a Clinical Sample of Youth at Risk of Suicide
Suicide Prevention, Social Media Users
Not yet recruitingPhase 1/2
Reducing Firearm Suicide Among Veterans: Evaluating the Effectiveness of Peer-Delivered Lethal Means Counseling
Suicide, Secure Firearm Storage
Recruiting
Developing a Recovery-Oriented Suicide Prevention Program for Young People at Clinical High Risk for Psychosis
Clinical High Risk for Psychosis (CHR), Suicidal Ideation
Not yet recruitingPhase 2
Intravenous Ketamine for Acute Suicidal Crisis and Psychiatric Hospital Length of Stay
Suicidal Ideation, Suicidal Behavior
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Jane Harness, DO principal investigator
University of Michigan
Cheryl King, PhD principal investigator
University of Michigan
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Papageno video in people with Suicide Prevention, run by University of Michigan at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Apr 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Suicidal ideation (time frame: Immediately before and after watching the video and at 3 months). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Apr 2026.